Neovacs SA (0LW1) Financial Statements

0 Followers

Neovacs SA Financial Overview

Neovacs SA's market cap is currently €47.72K. The company's EPS TTM is €-0.0658; its P/E ratio is -2.31; Neovacs SA is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 23	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 161.78K	€ 533.41K	€ 366.35K	€ 1.11K	€ 22.59K
Gross Profit	€ -4.52M	€ -6.75M	€ 42.42K	€ -6.26M	€ -7.60M
Operating Income	€ -5.43M	€ -6.91M	€ -6.76M	€ -6.44M	€ -7.84M
EBITDA	€ -5.24M	€ -8.45M	€ -6.61M	€ -3.61M	€ -10.38M
Net Income	€ -4.90M	€ -8.74M	€ -32.91M	€ -3.55M	€ -11.84M
Balance Sheet
Cash & Short-Term Investments	€ 571.79K	€ 887.09K	€ 435.45K	€ 6.76M	€ 33.09M
Total Assets	€ 22.14M	€ 47.53M	€ 22.07M	€ 49.28M	€ 48.55M
Total Debt	€ 537.20K	€ 650.59K	€ 230.37K	€ 1.20M	€ 1.03M
Net Debt	€ -34.58K	€ -236.50K	€ -205.07K	€ 1.16M	€ -15.22M
Total Liabilities	€ 4.10M	€ 3.71M	€ 4.01M	€ 5.05M	€ 4.65M
Stockholders' Equity	€ 18.03M	€ 43.82M	€ 18.06M	€ 44.23M	€ 43.90M
Cash Flow
Free Cash Flow	€ -5.04M	€ -2.12M	€ -3.68M	€ -4.60M	€ -10.26M
Operating Cash Flow	€ -5.03M	€ -1.91M	€ -3.60M	€ -4.45M	€ -9.91M
Investing Cash Flow	€ -446.17K	€ -11.08M	€ 1.45M	€ -31.56M	€ -18.81M
Financing Cash Flow	€ 5.62M	€ 6.79M	€ 1.70M	€ 9.99M	€ 51.75M

Currency in EUR

Neovacs SA Earnings and Revenue History

Income Statement >

Neovacs SA Debt to Assets

Balance Sheet >

Neovacs SA Cash Flow

Cash Flow >

Neovacs SA Forecast EPS vs Actual EPS

Earnings >